EnWave Subsidiary, Hans Binder Maschinenbau GmbH, Secures New Machine Orders

EnWave Corporation (TSX VENTURE:ENW)(FRANKFURT:E4U) ("EnWave", or the "Company")
is pleased to announce that its German subsidiary, Hans Binder Maschinenbau GmbH
("Binder"), has secured a machine order valued at approximately CDN$3,360,000,
contributing to a total of roughly CDN$5,700,000 in conventional dryer orders
from a variety of customers located throughout Europe, Africa and North America
over the past several months. Based on the Company's percentage of completion
accounting method, the majority of these orders are expected to be gradually
realized as revenue in the second half of calendar 2014 and Q1 calendar 2015. 


About Hans Binder Maschinenbau GmbH

Established in 1950, Hans Binder Maschinenbau GmbH designs and develops custom
driers and complete dehydration turn-key plants for customers worldwide from
their engineering and machine building operation in Marzling, Germany. Binder
has extensive experience in both the food and chemical industries with expertise
in vacuum microwave drying through their unique continuous tray-based method
sold under the MIVAP(TM) brand. For more information, please visit
www.hans-binder.de. 


About EnWave 

EnWave Corporation is a Vancouver-based industrial technology company developing
commercial applications for its proprietary Radiant Energy Vacuum (REV(TM))
dehydration technology. EnWave aims to sign royalty-bearing commercial licenses
with leading food and pharmaceutical companies for the use of its revolutionary
technology. Thus far the Company has signed ten royalty-bearing licenses,
opening up eight distinct market sectors for commercialization with companies
that include Bonduelle, a global leader in the production of vegetables; Hormel
Foods Corporation, a major processed meat manufacturer in the United States of
America; and Sutro Biopharma, a company developing a protein synthesis process
for the pharmaceutical industry. In addition to these licenses, EnWave has
formed a Limited Liability Partnership, NutraDried LLP, to develop, manufacture,
market and sell all-natural cheese snack products in the United States under the
Moon Cheese(R) brand. The Company has also signed a license and manufacturing
agreement with NutraDried Creations to market the dried cheese and other REV(TM)
snack products through private label distribution channels in the United States
and Latin America.


EnWave has signed a wide range of research agreements with an expanding list of
companies that include Nestle, Kellogg's, Ocean Spray Cranberries, Sun-Maid
Growers, R.J. Reynolds and Merck among others. EnWave is introducing REV(TM) as
a new dehydration standard in the food and biological material sectors:
potentially faster and cheaper than freeze drying, with better end product
quality than air drying or spray drying.


EnWave currently has six REV(TM) platforms: commercial-scale nutraREV(R) and
MIVAP(R) are used in the food industry to dry food products quickly and at
low-cost, while maintaining high levels of nutrition, taste, texture and colour.
The Company has also commercialized powderREV(R) for bulk dehydration of food
cultures, probiotics and fine biochemicals such as enzymes below the freezing
point; quantaREV(TM) for continuous, high-volume low-temperature drying; and
bioREV(TM) and freezeREV(TM) as new methods to stabilize and dehydrate
biopharmaceuticals such as vaccines and antibodies. More information about
EnWave is available at www.enwave.net. 




EnWave Corporation                                                          
Dr. Tim Durance                                                             
President & CEO                                                             



Safe Harbour for Forward-Looking Information Statements: This press release may
contain forward-looking information based on management's expectations,
estimates and projections. All statements that address expectations or
projections about the future, including statements about the Company's strategy
for growth, product development, market position, expected expenditures, and the
expected synergies following the closing are forward-looking statements. All
third party references to market information in this release are not guaranteed
to be accurate as the Company did not conduct the original primary research.
These statements are not a guarantee of future performance and involve a number
of risks, uncertainties and assumptions. Although the Company has attempted to
identify important factors that could cause actual results to differ materially,
there may be other factors that cause results not to be as anticipated,
estimated or intended. There can be no assurance that such statements will prove
to be accurate, as actual results and future events could differ materially from
those anticipated in such statements. Accordingly, readers should not place
undue reliance on forward-looking statements.


Neither the TSX Venture Exchange nor its Regulation Services Provider (as that
term is defined in the policies of the TSX Venture Exchange) accepts
responsibility for the adequacy or accuracy of this release.


FOR FURTHER INFORMATION PLEASE CONTACT: 
Mr. John Budreski
Executive Chairman
EnWave Corporation
[phone]
E-mail: [e-mail]


Mr. Brent Charleton
Vice President, Corporate Affairs
[phone]
E-mail: [e-mail]